Call for panel nominations
This article was originally published in The Tan Sheet
Executive Summary
Nominations for voting consumer representatives on CDER advisory committees will be accepted until the end of the year, FDA says in an April 13 Federal Register notice. Spots on the Nonprescription Drugs, Metabolic & Endocrinologic Drugs, Arthritis Drugs, Pulmonary-Allergy Drugs, Cardiovascular & Renal Drugs and Anti-Infective Drugs are open. Nominations should include a cover letter, CV or resume, and list of community or consumer groups in which the candidate is involved; self nominations will be accepted, FDA notes...